An anti-infective peptide that selectively modulates the innate immune response

Nature Biotechnology

Volumn 25, Issue 4, 2007, Pages 465-472

  Scott, Monisha G ^a   Dullaghan, Edie ^a   Mookherjee, Neeloffer ^b   Glavas, Natalie ^a   Waldbrook, Matthew ^b   Thompson, Annick ^a   Wang, Aikun ^a   Lee, Ken ^a   Doria, Silvana ^b   Hamill, Pam ^b   Yu, Jie Jessie ^b   Li, Yuexin ^b   Donini, Oreola ^a   Guarna, M Marta ^a   Finlay, B Brett ^c   North, John R ^a   Hancock, Robert E W ^b  

^a Inimex Pharmaceuticals Inc   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCYTE CHEMOKINES; MOUSE MONOCYTES; PROTEIN EXPRESSION; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM;

BACTERIA; GENE EXPRESSION; MACROPHAGES; PATHOGENS; TOXICITY;

PEPTIDES;

CHEMOKINE; CYTOKINE; INNATE DEFENSE REGULATOR 1 PEPTIDE; MITOGEN ACTIVATED PROTEIN KINASE; PEPTIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CONTROLLED STUDY; EFFECTOR CELL; FEMALE; GENE EXPRESSION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; HUMAN CELL; IMMUNOMODULATION; INNATE IMMUNITY; MACROPHAGE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MONOCYTE; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALMONELLA ENTERICA; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ANIMALS; ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, NATURAL; INFLAMMATION; LIPOPOLYSACCHARIDES; MICE; MODELS, IMMUNOLOGICAL; PEPTIDES; TREATMENT OUTCOME;

ENTEROCOCCUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEGIBACTERIA; POSIBACTERIA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM;

EID: 34147147029     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1288     Document Type: Article

References (29)

1. Theuretzbacher, U. & Toney, J.H. Nature's clarion call of antibacterial resistance: are we listening? Curr. Opin. Investigat. Drugs 7, 158-166 (2006).
2. Spellberg, B. et al. Trends in Antimicrobial Drug Development: Implications for the Future. Clin. Infect. Dis. 38, 1279-1286 (2004).
3. Finlay, B.B. & Hancock, R.E.W. Can innate immunity be enhanced to treat infections? Nat. Rev. Microbiol. 2, 497-504 (2004).
4. National Research Council Treating Infectious Diseases in a Microbial World: Report of Two Workshops. Washington, D.C.: The National Academies Press, (2005).
5. O'Neill, L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18, 3-9 (2006).
6. Pasare, C. & Medzhitov, R. Toll-like receptors: linking innate and adaptive immunity. Adv. Exp. Med. Biol. 560, 11-18 (2005).
7. Tosi, M.F. Innate immune responses to infection. J. Allergy Clin. Immunol. 116, 241-249 (2005).
8. Martinon, F. & Tschoop, J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26, 447-454 (2005).
9. Oppenheim, J.J. & Yang, D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 17, 359-365 (2005).
10. Bowdish, D.M.E. et al. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 77, 451-459 (2005).
11. Mookherjee, N. et al. Modulation of the Toll-like receptor-mediated inflammatory response by the endogenous human host defence peptide LL-37. J. Immunol. 176, 2455-2464 (2006).
12. Niyonsaba, F. et al. Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells. Eur. J. Immunol. 31, 1066-1075 (2001).
13. Lau, Y.E. et al. Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37. Am. J. Respir. Cell Mol. Biol. 34, 399-409 (2006).
14. Bowdish, D.M.E., Davidson, D.J., Scott, M.G. & Hancock, R.E.W. Immunomodulatory activities of small host defence peptides. Antimicrob. Agents Chemother. 49, 1727-1732 (2005).
15. Tsuji, M. et al. In vivo antibacterial activity of S-3578, a new broad-spectrum cephalosporin: methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa experimental infection models. Antimicrob. Agents Chemother. 47, 2507-2512 (2003).
16. Gehlhar, K. et al. Characterization of modified allergen extracts by in vitro beta-hexosaminidase release from rat basophils. Int. Arch. Allergy Immunol. 136, 311-319 (2005).
17. Hanlon, M., Sturgill, T.W. & Sealy, L. ERK2- and p90(Rsk2)-dependent pathways regulate the CCAAT/enhancer-binding protein-beta interaction with serum response factor. J. Biol. Chem. 276, 38449-38456 (2001).
18. Marcinkowska, E. et al. Regulation of C/EBPbeta isoforms by MAPK pathways in HL60 cells induced to differentiate by 1,25-dihydroxyvitamin D3. Exp. Cell Res. 312, 2054-2065 (2006).
19. Fessele, S. et al. Molecular and in silico characterization of a promoter module and C/EBP element that mediate LPS-induced RANTES/CCL5 expression in monocytic cells. FASEB J. 15, 577-579 (2001).
20. Williams, S.C. et al. C/EBP is a myeloid-specific activator of cytokine, chemokine, and macrophage-colony-stimulating factor receptor genes. J. Biol. Chem. 273, 13493-13501 (1998).
21. Kubota, T. et al. Representational difference analysis using myeloid cells from C/EBP epsilon deletional mice. Blood 96, 3953-3957 (2000).
22. Prins, J.M. et al. Release of tumor necrosis factor and interleukin 6 during antibiotic killing of Escherichia coli in whole blood: influence of antibiotic class, antibiotic concentration, and presence of septic serum. Infect. Immun. 63, 2236-2242 (1995).
23. Zisman, D.A. et al. Standiford TJ. MCP-1 protects mice in lethal endotoxemia. J. Clin. Invest. 99, 2832-2836 (1997).
24. Cavaillon, J.M., Adib-Conquy, M., Fitting, C., Adrie, C. & Payen, D. Cytokine cascade in sepsis. Scand. J. Infect. Dis. 35, 535-544 (2003).
25. Brenner, S. et al. cAMP-induced Interleukin-10 promoter activation depends on CCAAT/enhancer-binding protein expression and monocytic differentiation. J. Biol. Chem. 278, 5597-5604 (2003).
26. Zwergal, A. et al. C/EBPbeta blocks p65 phosphorylation and thereby NFκB-mediated transcription in TNF-tolerant Cells. J. Immunol. 177, 665-672 (2006).
27. Cote, C.K., Van Rooijen, N. & Welkos, S.L. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 74, 469-480 (2006).
28. Pfaffl, M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
29. Hokamp, K. et al. ArrayPipe: a flexible processing pipeline for microarray data. Nucleic Acids Res. 32 (Web Server issue), W457-459 (2004).